MyoKardia, Inc. today announced the pricing of its initial
public offering of 5,437,500 shares of common stock at a public offering
price of $10.00 per share, before underwriting discounts and
commissions. All of the common stock is being offered by MyoKardia. In
addition, MyoKardia has granted the underwriters a 30-day option to
purchase up to an additional 815,625 shares of common stock from the
company at the public offering price. The company's shares are expected
to begin trading on The NASDAQ Global Select Market on October 29, 2015
under the ticker symbol "MYOK." The offering is expected to close on
November 3, 2015 subject to customary closing conditions.
Credit Suisse Securities (USA) LLC and Cowen and Company, LLC are
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in